XML 45 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Note 21 - Segment Reporting
 12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 21. SEGMENT REPORTING

 

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

 

Prior to the DERMAdoctor Acquisition in November 2021 (see Note 3, Business Combination), the Company was managed as a single segment focused on commercializing Avenova Spray in the United States. After the DERMAdoctor Acquisition, the Company began managing and aggregating its operational and financial information in accordance with two reportable segments: (1) Optical &Wound Care and (2) Skin Care. The Optical & Wound Care segment consists of products historically sold by NovaBay prior to the DERMAdoctor Acquisition. The Skin Care segment consists of products acquired in the DERMAdoctor Acquisition and skincare products subsequently sold under the DERMAdoctor brand.

 

Select financial information for each segment is as follows:

 

  

Year

Ended

  

Percentage

 
  

December 31,

2021

  

of Total

Revenue

 

Optical & Wound Care

 $7,834   93

%

Skincare

  587   7

%

         

Total revenue

 $8,421   100

%

 

  

Year

Ended

  

Percentage

 
  

December 31,

2021

  

of Total Gross

Margin

 

Optical &Wound Care

 $5,336   95

%

Skincare

  309   5

%

         

Total gross margin

 $5,645   100

%